|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of Goods Sold | |||||
| Gross Profit | |||||
| Operating Expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| Selling and marketing | |||||
| Loss on impairment of right-of-use assets | |||||
| Total Operating Expenses | |||||
| Loss From Operations | |||||
| Other (Expense) Income | |||||
| Interest expense, net | |||||
| Other (expense) income | |||||
| Interest expense, net | |||||
| Change in fair market value of warrant liability | |||||
| Debt extinguishment | |||||
| Total Other Expense | |||||
| Net Loss Before Taxes | |||||
| Income Tax Expense (Benefit) | |||||
| Net Loss | |||||
| Less: Preferred Stock Dividends | |||||
| Net Loss Attributable to Common Shareholders | |||||
| Loss Per Share- Basic | |||||
| Loss Per Share- Diluted | |||||
| Weighted Average Number of Shares - Basic | |||||
| Weighted Average Number of Shares - Diluted | |||||
Loading...